SCHEMBL15974247

SCHEMBL15974247

CCCCOC(=O)N1CC(C(O)CO)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GBA2 Q9HCG7 1/20 0.42
ALDH1A1 P00352 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
ATM Q13315 1/20 0.37
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
BCHE P06276 1/20 0.35
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
MMP13 P45452 1/20 0.34
KDM4E B2RXH2 1/20 0.33
DUSP3 P51452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6415295 0.82 LMNA (0.44) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL12468609 0.81 SMN1; SMN2 (0.47) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL12468859 0.81 SMN1; SMN2 (0.47) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL4968757 0.79 LMNA (0.53) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL1633241 0.78 LMNA (0.56) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL20912047 0.78 POLB (0.56) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL18498621 0.78 LMNA (0.56) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL3652718 0.78 LMNA (0.56) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL29850834 0.78 LMNA (0.56) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL19308675 0.77 SMN1; SMN2 (0.54) LMNAPOLBSMN1; SMN2GBA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2958562-A1 ANTIDIABETIC BICYCLIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2015-12-30 EP disclosed
WO-2014130608-A1 ANTIDIABETIC BICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2014-08-28 WO disclosed